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During postnatal development, the switch of the expression from isoform A1 to the isoform A2 of eukaryotic
translation elongation factor (eEF1A) is observed in neuronal and muscle tissues. The switch of the expression is
a vital fundamental process, as mutant mice, with the partial EEF1A2 deletion dies on the 28
th
day after birth.
Mechanism of the inhibition of A1 and stimulation of A2 expression during the first days of postnatal
development is unknown. The existence of potential miRNA binding sites in the 3'UTR of mRNAs encoding the
isoforms assumes a post-transcriptional control of abovementioned phenomenon. Aim. To check the possibility
of post-transcriptional regulation of the isoforms A1 and A2 expression during differentiation of the human
immorta- lized myoblasts cell line LHCN. Methods. The level of gene expression was quantified by qPCR, the
existence of post-transcriptional regulation was demonstrated with Dual-Luciferase
®
Reporter Assay. Results.
Using immortalized human myoblasts cell line LHCN, the induction of isoform A2 of eEF1 during differentiation
of myoblasts was shown. The existence of transcriptional and post-transcriptional control of the abo-
vementioned process was confirmed. Downregulation of mir-661 and mir-744 that have binding sites in the 3'
UTR of EEF1A2 mRNA, during differentiation suggests a potential role of microRNAs in the eEF1A2 induction
during myoblast differentiation. Conclusions. Induction of A2 isoform of eEF1 during differentiation of
myoblasts occurs on transcriptional and post-transcriptional level.
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Introduction. Eukaryotic translation elongation factor
(eEF1A) is one of crucial elements of protein synthesis
[1]. The main eEF1A function is the delivery of amino-
acyl tRNAs to A-site of ribosome [2]. The isoform A1,
eEF1A1, is more widespread and expressed in all
tissues during embryogenesis. However, during the
postnatal period of development some tissues showed
the decrease and standstill of the eEF1A1 expression
accompanied by the induction of the expression of the
A2 isoform, eEF1A2 [3, 4]. Such changes are specific
exclusively for terminally differentiated cells, particu-
larly neurons, cardiomyocytes, and myocytes [5, 6]. As
of now, the question about the mechanism and
physiological significance of the switch of the ex-
pression of isoforms remains unsolved. The absence of
A2 isoform as a result of the partial deletion of EEF1A2
gene in wst/wst mutant mice, was lethal. These mice
showed gradual downregulation in A1 expression with
no replacement by A2. The phenotype of such mice is
described by the loss of body weight, tremor,
pathologies of muscular and nervous systems. On day
28 after the birth, these allele homozygotes died [7].
These isoforms are 98 % homologous, yet, regard-
less of high homology and probably similar translation
efficiency, these proteins differ significantly in their
non-canonical functions [8, 9]. eEF1A1 shows pro-
apoptotic features, whereas eEF1A2 is antiapoptotic
[10]. There are data confirming proto-oncogenic nature
of eEF1A2 [11]. A2 isoform was shown to appear in
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cancer tissues of mammary gland, lungs, and ovaries
[12].
Regardless of high protein homology, mRNA enco-
ding the A1 and A2 isoforms differ in 3' and 5' untran-
slated regions (UTR) considerably, which suggests
probability of different control of post transcriptional
expression of isoforms. MicroRNA is known to be one
of principal participants of the post-transcriptional con-
trol system [13]. The existence of sites specific for di-
fferent microRNAs in UTRs of mRNA coding for A1
or A2 suggests their participation in the post-tran-
scriptional control of the expression switch from the A1
to A2 isoform. This paper presents experimentally con-
firmed hypothesis about possibility of post-transcripti-
onal control in the expression switch between the eEF1A
isoforms during differentiation of myoblasts. The
involvement of microRNA in this process is shown.
Materials and Methods. Cell culture. Cultivation
and differentiation of immortalized human myoblasts
LHCN were performed as described in [14].
cDNA synthesis, qPCR. Total RNA was extracted
from (1-2)·106 cells, using TRI-reagent (Sigma Chem.
Co, USA). cDNA was synthesized by reverse tran-
scriptase RevertAid (Fermentas, Lithuania) and oligod
T-primer following the manufacturer's recommen-
dations. Quantitative PCR was performed as described
in [15]. Relative quantity of mRNA eEF1A1/A2 was
normalized to beta-actin mRNA. Quantitative PCR-
analysis of microRNA was performed using TaqMan®
MicroRNA Assays kit (Applied Biosystems, USA), fo-
llowing the manufacturer's recommendations.
Reporter gene assay. Proliferating or differentiated
LHCN cells were transfected with 20 ng of plasmid,
containing the open reading frame of luciferase and
3'-UTR of EEF1A1/A2 mRNA using Lipofectamine
2000 (Invitrogene, USA), following the manufacturer's
instructions. 24 hours later the luciferase level was
measured using Dual-Luciferase® Reporter Assay Sys-
tem as described by the manufacturer.
Results and Discussion. The immortalized human
myoblasts were obtained by the transformation with
telomerase and cyclin-dependent kinase 4 [14]. The
obtained cell line was capable of proliferation as
non-differentiated myoblasts as well as differentiating
myoblasts with subsequent formation of myocytes. The
main criterion for the use of LHCN cells for studying
the regulation of A1 and A2 expression was switchable
expression of the isoforms after the differentiation.
Thus, we compared expression of the isoforms in non-
differentiated myoblasts and on day 6 of the diffe-
rentiation. The twenty-fold increase in the expression
of mRNA of isoform A2 was observed after the diffe-
rentiation (Fig. 1), demonstrating organism-like beha-
viour [7]. At the same time, there was less significant
than for EEF1A2, yet statistically credible five-fold
increase in EEF1A1 mRNA.
MicroRNAs play an important role during the diffe-
rentiation of myoblasts and the development of patho-
logies of muscular and cardiac tissues [16]. To check a
possible participation of microRNA in the regulation of
expression of the isoforms during the differentiation of
myoblasts, we analyzed in silico microRNA binding
sites in 3'-UTR of mRNA EEF1A1/A2. mRNA of the
eEF1A1 isoform contains mir-133, mir-543, mir-33
binding sites, and mRNA of EEF1A2 could contain
binding sites of mir-744, mir-661 and mir-675. Note-
worthy, unlike EEF1A2, 3'-UTR of EEF1A1 mRNA
contains the binding site for mir-133, the crucial
microRNA for the differentiation of myoblasts [16].
The correlation of the switch in the expression of
microRNA with disordered expression of target pro-
teins is one of the facts testifying for the existence of
post-transcriptional control over these proteins. The
quantitative PCR-analysis of the level of expression of
all microRNAs, envisaged by the bioinformatic
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Fig. 1 The switch in the expression of isoforms of elongation
translation factor eEF1 during the differentiation of myoblasts. The
quantitative PCR-analysis of mRNA of EEF1A1/A2 in proliferating
myoblasts (1) and differentiated myocytes (2); *p < 0.05; t-Student’s
test
VISLOVUKH A. A. ET AL.
method, showed five hundred-fold increase in the
mir-133 content (Fig. 2). Such significant increase
could also cause the post-transcriptional blockage of
EEF1A1 mRNA. Isoform A2 demonstrated regulation
by two microRNAs, mir-744 and mir-661, the expre-
ssion of which decreased during the differentiation by
13 and 36 %, respectively. The reduction in the content
of these microRNAs correlates with the increase in the
quantity of EEF1A2 mRNA during the differentiation
(Fig. 1).
We used the method of reporter genes to prove the
possibility of the post-transcriptional control of the
switch of isoforms during the differentiation of myo-
blasts. Proliferating myoblasts and differentiated
myocytes after six days of differentiation were trans-
fected by a reporter plasmid, containing 3'-UTR of
mRNAs coding for A1 or A2, respectively. The ex-
perimental results demonstrated almost two-fold in-
crease in the level of luciferase with 3'UTR mRNA A2
(Fig. 3), which correlated with earlier obtained data
about the increase in the quantity of A2 mRNA and the
reduction of the level of expression of microRNA,
which potentially regulate A2 (Fig. 1, 2). At the same
time we detected some positive post-transcriptional
regulation of expression of the reporter gene for A1
(Fig. 3).
Twenty-fold change in the A2 expression at the
mRNA level and two-fold change in case of application
of the reporter vector fused with 3'-UTR of A2 mRNA
may testify for some contribution of the post-transcrip-
tional regulation in the positive control of the expre-
ssion of mRNA of isoform A2 during the differentia-
tion of myoblasts.
Thus, the stimulation of the EEF1A2 mRNA ex-
pression during the differentiation occurs at both tran-
scriptional and post-transcriptional levels. At the same
time, the inhibition of the A1 isoform, highly expressed
in all tissues [14], apparently requires a regulation
which could be more powerful than microRNA.
Indeed, even highly expressed mir-133 does not inhibit
EEF1A1 expression in our experiments, which
correlates with the literature data [17].
Conclusions. The results obtained demonstrate that
the induction of EEF1A2 expression during myoblasts
differentiation is controlled at both transcriptional and
post-transcriptional levels. Besides, the increase in the
expression of mRNA coding for the isoform A2 and the
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Fig. 2 The expression of microRNA with
envisaged binding sites in 3’-NTS
mRNA EEF1A1/A2 during the
differentiation of myoblasts. The
quantitative PCR-analysis of myoblasts
in proliferating myoblasts (1) and
differentiating myocytes (2)
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Fig. 3 The post-transcriptional control of the expression of isoforms of
translation elongation factor eEF1 during the differentiation of
myoblasts. Proliferating myoblasts (1) or differentiating myocytes (2)
of LHCN were transfected by reported plasmids, containing the open
reading frame of luciferase and 3’-UTR EEF1A1/A2: a – pSICHECK
+ EEF1A1 3’-UTR; b – pSICHECK + EEF1A2 3’-UTR; c –
pSICHECK-2; t-Student’s test. The level of luciferase was measured
after 24 h of incubation; *p < 0.05; t-Student’s test
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reporter gene, containing 3'-UTR of mRNA coding for
eEF1A2, correlates with the decrease in the expression
of mir-744 and mir-661 possessing predicted binding
sites in 3'-UTR of EEF1A2 mRNA. This fact suggests
that these microRNAs participate in the
post-transcriptional control of this isoform expression.
Unexpected was the increase in the A1 isoform
expression after the differentiation of myoblasts, which
is not characteristic of this process in vivo. This could
be explained by artificial conditions of differentiation,
namely, the use of insulin as one of the main
components of the "differentiation" medium. This
hormone was shown to stimulate expression of mRNA,
containing oligopyrimidine tract in 5'-UTR [18].
EEF1A1 mRNA belongs to this class of mRNA [19].
The obtained data contribute significantly to the
understanding of the fundamental mechanisms of the
differentiation of myoblasts and may help in further
elucidation of the mechanisms of cancer development,
as occurrence of the A2 isoform in unspecific tissues
results in malignant transformation of cells [10].
Nevertheless, the negative regulation of eEF1A1 in
muscular and nervous tissues remains an open issue and
requires further investigation.
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Òðàíñêðèïö³éíèé ³ ïîñòòðàíñêðèïö³éíèé êîíòðîëü åêñïðåñ³¿
eEF1A2 ó ïðîöåñ³ äèôåðåíö³àö³¿ ì³îáëàñò³â
1
Äåðæàâíà êëþ÷îâà ëàáîðàòîð³ÿ ìîëåêóëÿðíî¿ ³ êë³òèííî¿ á³îëîã³¿
²íñòèòóò ìîëåêóëÿðíî¿ á³îëîã³¿ ³ ãåíåòèêè ÍÀÍ Óêðà¿íè
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2
Íàö³îíàëüíèé öåíòð íàóêîâèõ äîñë³äæåíü (CNRS) òà Êîì³ñàð³àò
àòîìíî¿ åíåðãåòèêè (CEA)
Ñàêëå, Æèô-ñþð-²âåò, Ôðàíö³ÿ, F-91191
Ðåçþìå
Ó ïðîöåñ³ ïîñòíàòàëüíîãî ðîçâèòêó â íåéðîíàëüí³é ³ ì’ÿçîâ³é
òêàíèíàõ â³äáóâàºòüñÿ çì³íà ³çîôîðìè À1 ôàêòîðà åëîíãàö³¿
òðàíñëÿö³¿ íà ³çîôîðìó À2. Ïåðåìèêàííÿ åêñïðåñ³¿ ³çîôîðì º
æèòòºâî âàæëèâîþ ïîä³ºþ, îñê³ëüêè ìóòàíòí³ ìèø³, ùî
ì³ñòÿòü äåëåö³þ EEF1A2, ãèíóòü íà 28-é äåíü ï³ñëÿ íàðîäæåííÿ.
Ìåõàí³çìè ³íã³áóâàííÿ À1 ³ ñòèìóëÿö³¿ À2 ïðîòÿãîì ïåðøèõ äí³â
ïîñòíàòàëüíîãî ðîçâèòêó íåâ³äîì³. Íàÿâí³ñòü ñàéò³â çâ’ÿçóâàí-
íÿ ì³êðîÐÍÊ ó 3'-íåòðàíñëüîâàíèõ ïîñë³äîâíîñòÿõ ìÐÍÊ ³çî-
ôîðì ôàêòîðà åëîíãàö³¿ òðàíñëÿö³¿ ïåðåäáà÷àº ³ñíóâàííÿ
ïîñòòðàíñêðèïö³éíîãî êîíòðîëþ äàíîãî ïðîöåñó. Ìåòà. Ïå-
ðåâ³ðèòè ìîæëèâ³ñòü ïîñòòðàíñêðèïö³éíî¿ ðåãóëÿö³¿ åêñïðåñ³¿
³çîôîðì À1 ³ À2 ï³ä ÷àñ äèôåðåíö³àö³¿ ³ì- ìîðòàë³çîâàíèõ ì³îá-
ëàñò³â ëþäèíè LHCN.Ìåòîäè. Ð³âåíü åêñïðåñ³¿ ãåí³â âèçíà÷àëè ìå-
òîäîì ê³ëüê³ñíî¿ ÏËÐ, íàÿâí³ñòü ïîñòòðàíñêðèïö³éíîãî êîíòðî-
ëþ äåòåêòóâàëè ìåòîäîì ðåïîðòåðíèõ ãåí³â. Ðåçóëüòàòè.
Âèêîðèñòîâóþ÷è ÿê ìîäåëü êë³òèííó ë³í³þ ³ììîðòàë³çîâàíèõ
ì³îáëàñò³â ëþäèíè LHCN, ïîêàçàíî ³íäóêö³þ ³çîôîðìè À2 ôàêòî-
ðà åëîíãàö³¿ òðàíñëÿö³¿ eEF1 ïðè äèôåðåíö³àö³¿ ì³îáëàñò³â, íà-
ÿâí³ñòü òðàíñêðèïö³éíîãî ³ ïîñòòðàíñêðèïö³éíîãî êîíòðîëþ â
äàíîìó ïðîöåñ³, à òàêîæ ïîòåíö³éíó ó÷àñòü ì³êðî- ÐÍÊ ó ïðî-
öåñ³ çì³íè åêñïðåñ³¿ ³çîôîðì.Âèñíîâêè. ²íäóêö³ÿ ³çîôîðìè À2 ïðî-
òÿãîì äèôåðåíö³àö³¿ ì³îáëàñò³â ìîæå â³äáóâàòèñÿ ÿê íà
òðàíñêðèïö³éíîìó, òàê ³ íà ïîñòòðàíñêðèïö³éíîìó ð³âí³.
Êëþ÷îâ³ ñëîâà: eEF1A1, eEF1A2, ³ììîðòàë³çîâàí³ ì³îáëàñòè
ëþäèíè LHCN, äèôåðåíö³àö³ÿ, ì³êðîÐÍÊ.
À. À. Âèñëîâóõ, ². Ñ. Ãðîéñìàí, À. Â. Åëüñêàÿ, Á. Ñ. Íåãðóöêèé,
À. Í. Ïîëåññêàÿ
Òðàíñêðèïöèîííûé è ïîñòòðàíñêðèïöèîííûé êîíòðîëü
ýêñïðåññèè eEF1A2 â ïðîöåññå äèôôåðåíöèàöèè ìèîáëàñòîâ
Ðåçþìå
Â ïðîöåññå ïîñòíàòàëüíîãî ðàçâèòèÿ â íåéðîíàëüíîé è ìûøå÷-
íîé òêàíÿõ ïðîèñõîäèò èçìåíåíèå ýêñïðåññèè èçîôîðìû À1 ôàê-
òîðà ýëîíãàöèè òðàíñëÿöèè íà ýêñïðåññèþ èçîôîðìû À2. Ïåðå-
êëþ÷åíèå ýêñïðåññèè èçîôîðì ÿâëÿåòñÿ æèçíåííî âàæíûì ôóí-
äàìåíòàëüíûì ïðîöåññîì, ïîñêîëüêó ìóòàíòíûå ìûøè, ñîäåð-
æàùèå äåëåöèþ ÷àñòè ãåíà EEF1A2, ïîãèáàþò íà 28-é äåíü ïîñëå
ðîæäåíèÿ. Ìåõàíèçìû èíãèáèðîâàíèÿ ýêñïðåññèè À1 è ñòèìóëÿ-
öèè À2 â òå÷åíèå ïåðâûõ äíåé ïîñòíàòàëüíîãî ðàçâèòèÿ íåèçâå-
ñòíû. Íàëè÷èå ïîòåíöèàëüíûõ ñàéòîâ ñâÿçûâàíèÿ ìèêðîÐÍÊ â 3'-
íåòðàíñëèðóåìûõ ïîñëåäîâàòåëüíîñòÿõ ìÐÍÊ èçîôîðì ôàêòî-
ðà ýëîíãàöèè òðàíñëÿöèè ïðåäóñìàòðèâàåò âîçìîæíîñòü ïîñò-
òðàíñêðèïöèîííîãî êîíòðîëÿ äàííîãî ïðîöåññà. Öåëü. Ïðîâåðèòü
âîçìîæíîñòü ïîñòòðàíñêðèïöèîííîé ðåãóëÿöèè ýêñïðåññèè èçî-
ôîðì À1 è À2 âî âðåìÿ äèôôåðåíöèàöèè èììîðòàëèçîâàííûõ ìèî-
áëàñòîâ ÷åëîâåêà LHCN.Ìåòîäû. Óðîâåíü ýêñïðåññèè ãåíîâ îïðå-
äåëÿëè ìåòîäîì êîëè÷åñòâåííîãî ÏËÐ, íàëè÷èå ïîñòòðàíñêðèï-
öèîííîãî êîíòðîëÿ äåòåêòèðîâàëè ìåòîäîì ðåïîðòåðíèõ ãåíîâ.
Ðåçóëüòàòû. Èñïîëüçóÿ êëåòî÷íóþ ëèíèþ èììîðòàëèçîâàííûõ
ìèîáëàñòîâ ÷åëîâåêà LHCN êàê ìîäåëü, ïîêàçàíà èíäóêöèÿ èçî-
ôîðìû À2 ôàêòîðà ýëîíãàöèè òðàíñëÿöèè eEF1 ïðè äèôôåðåí-
öèàöèè ìèîáëàñòîâ, íàëè÷èå òðàíñêðèïöèîííîãî è ïîñòòðàíñ-
êðèïöèîííîãî êîíòðîëÿ â äàííîì ïðîöåññå, à òàêæå ïîòåíöèàëü-
íîå ó÷àñòèå ìèêðîÐÍÊ â ïðîöåññå èçìåíåíèÿ ýêñïðåññèè èçîôîðì.
Âûâîäû. Èíäóêöèÿ èçîôîðìû À2 ïðè äèôôåðåíöèàöèè ìèîáëà-
ñòîâ ìîæåò ïðîèñõîäèòü êàê íà òðàíñêðèïöèîííîì, òàê è íà
ïîñòòðàíñêðèïöèîííîì óðîâíå.
Êëþ÷åâûå ñëîâà: eEF1A1, eEF1A2, èììîðòàëèçîâàííûå ìèî-
áëàñòû ÷åëîâåêà LHCN, äèôôåðåíöèàöèÿ, ìèêðîÐÍÊ.
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